Cancer Imaging with Radiolabeled Antibodies: Cancer Treatment and Research, cartea 51
Editat de David M. Goldenbergen Limba Engleză Hardback – 31 mai 1990
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 2033.99 lei 6-8 săpt. | |
Springer Us – 26 sep 2011 | 2033.99 lei 6-8 săpt. | |
Hardback (1) | 2041.03 lei 6-8 săpt. | |
Springer Us – 31 mai 1990 | 2041.03 lei 6-8 săpt. |
Din seria Cancer Treatment and Research
- 14% Preț: 960.70 lei
- 14% Preț: 632.65 lei
- 5% Preț: 757.81 lei
- 5% Preț: 998.60 lei
- 5% Preț: 993.53 lei
- 5% Preț: 1002.30 lei
- 5% Preț: 882.70 lei
- 5% Preț: 691.82 lei
- 5% Preț: 885.33 lei
- 5% Preț: 472.91 lei
- 5% Preț: 651.84 lei
- 5% Preț: 491.35 lei
- 5% Preț: 693.92 lei
- 5% Preț: 356.46 lei
- 15% Preț: 673.63 lei
- 5% Preț: 2036.46 lei
- 5% Preț: 1360.44 lei
- 5% Preț: 1370.13 lei
- 5% Preț: 1064.76 lei
- 5% Preț: 1248.42 lei
- 5% Preț: 1061.43 lei
- 5% Preț: 1052.98 lei
- 5% Preț: 1054.90 lei
- 5% Preț: 1359.94 lei
- 5% Preț: 692.87 lei
- 5% Preț: 680.04 lei
- 5% Preț: 703.44 lei
- 5% Preț: 1361.14 lei
- 5% Preț: 1066.68 lei
- 5% Preț: 1056.49 lei
- 5% Preț: 1050.84 lei
- 5% Preț: 1057.89 lei
- 5% Preț: 1064.42 lei
Preț: 2041.03 lei
Preț vechi: 2148.46 lei
-5% Nou
Puncte Express: 3062
Preț estimativ în valută:
390.63€ • 412.09$ • 325.53£
390.63€ • 412.09$ • 325.53£
Carte tipărită la comandă
Livrare economică 03-17 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780792306313
ISBN-10: 0792306317
Pagini: 468
Ilustrații: XXII, 468 p.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 0.86 kg
Ediția:1990
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
ISBN-10: 0792306317
Pagini: 468
Ilustrații: XXII, 468 p.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 0.86 kg
Ediția:1990
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I. Historical and Theoretical Perspectives.- 1. Clinical radioimmunodetection: The second decade.- 2. Antibody targeting: Theoretical considerations.- II. Model Systems.- 3. Experimental model systems for antibody targeting and radioimmunodetection.- 4. Preclinical models and methods for the study of radiolabeled monoclonal antibodies in cancer diagnosis and therapy.- 5. Physiology of monoclonal antibody accretion by tumors.- 6. Intraperitoneal delivery of monoclonal antibodies.- III. Radiochemistry.- 7. Chelates and antibodies: Current methods and new directions.- 8. Radiolabeling antibodies via the cyclic anhydride of DTPA — Experiences of 5 years.- 9. Bifunctional chelating agents for radiometal-labeled monoclonal antibodies.- 10. Optimization of biodistribution by introducing different chemical linkages between antibody and an indium-111 chelate.- 11. Novel bifunctional linkers for antibody chelation with radiometals.- 12. Labeling of anti-tumor antibodies and antibody fragments with Tc-9m.- IV. Clinical Studies.- 13. Requirements for the use of radioimmunodetection of cancer in clinical practice.- 14. In-vivo antibody imaging for the detection of human tumors.- 15. In-111 monoclonal antibody immunoscintigraphy of colorectal cancer.- 16. Tumor targeting with monoclonal antibody B72.3: Experimental and clinical results.- 17. Antibody imaging of endocrine tumors.- 18. Diversity of the human immune response to clinically used murine monoclonal antibodies.- V. New Approaches.- 19. Antibody lymphoscintigraphy.- 20. Radioimmunoguided surgery: A new intraoperative approach to the detection of tumor.- 21. Augmentation of tumor antigen expression by recombinant human interferons: Enhanced targeting of monoclonal antibodies to carcinomas.- 22. Anti-antibody enhancement oftumor imaging.
Recenzii
` It is recommended for laboratory investigators who seek detailed information on many of the important issues in radioimmunodetection research and for clinical investigators active in this area, who will benefit from comparing a variety of viewpoints on the major problems that still need to be solved.'
Cancer Cells, 3:1, 1991
Cancer Cells, 3:1, 1991